Mission Street and BGO have let 8,300 sq ft to UK biotech company Orbit Discovery at the Inventa innovation district in Oxford’s West End.
Orbit Discovery, which was spun out of the University of Oxford in 2016, provides peptide discovery services for therapeutic applications.
Colin Brown, development director at Mission Street, said: “We’re delighted to welcome Orbit Discovery as the latest occupier at Inventa. We have really enjoyed getting to know the team at Orbit better and we will be undertaking works in the building to provide them with exceptional space for the next period of their company growth. Inventa is now nearing full occupancy, housing some of Oxford’s most exciting innovation companies and establishing a thriving research and development cluster.”
Brett Rowley, VP of finance at Orbit Discovery, added: “We spent a great deal of time testing the market in our search for our new premises, but we landed at Inventa for a variety of reasons. We were particularly drawn by the building’s central location, the unique building design and the quality of the space both in common areas and within our premises. We look forward to moving into our modern labs and office space early in the new year.”
